CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CELC — Celcuity Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,571,825
+$26,993 QoQ
Shares Held
320,893
+9.2% QoQ
Ownership
0.656%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 274 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,345,286,205 across 298 Biotechnology names. CELC ranks #44 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in CELC
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,571,825 | 320,893 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $33,544,832 | 293,892 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,155,498 | 292,315 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,276,200 | 268,749 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,111,337 | 233,059 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,345,883 | 232,036 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,111,571 | 237,706 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,305,114 | 221,671 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,113,168 | 67,959 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $978,760 | 45,313 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $659,685 | 45,277 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $430,960 | 47,151 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $486,677 | 44,324 | Shares | Sole | 2023-08-10 | |
| 2022-03-31 | $255,030 | 27,276 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $333,535 | 25,287 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $455,166 | 25,287 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $465,720 | 19,405 | Shares | Sole | 2021-08-16 | |
| 2020-03-31 | $95,608 | 14,709 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||